Alterity Therapeutics to Present at Life Sciences Webinar
Ticker: PRNAF · Form: 6-K · Filed: Jun 13, 2024 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Jun 13, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: presentation, registration-statement, life-sciences
TL;DR
ALTERITY presenting at a webinar, filing incorporated into S-8/F-3 registration statements.
AI Summary
Alterity Therapeutics Limited announced on June 13, 2024, that it will present at the Hidden Gems in Life Sciences Webinar. This filing incorporates by reference the announcement into existing Registration Statements on Form S-8 and Form F-3.
Why It Matters
Presentations at industry events can increase visibility and attract potential investors or partners for the company's therapeutic development programs.
Risk Assessment
Risk Level: low — This filing is an informational announcement and does not involve new financial transactions or significant operational changes.
Key Players & Entities
- Alterity Therapeutics Limited (company) — Registrant
- Hidden Gems in Life Sciences Webinar (event) — Presentation topic
- Form S-8 (filing) — Incorporated by reference
- Form F-3 (filing) — Incorporated by reference
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is being incorporated by reference into Alterity Therapeutics Limited's existing Registration Statements on Form S-8 and Form F-3, and it announces the company's participation in the Hidden Gems in Life Sciences Webinar.
When was this filing submitted?
The filing was submitted on June 13, 2024.
What is the company's principal executive office address?
The company's principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
What other forms are referenced in this filing?
This filing is incorporated by reference into Registration Statements on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076).
What is the SIC code for Alterity Therapeutics Limited?
The Standard Industrial Classification (SIC) code for Alterity Therapeutics Limited is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 194 words · 1 min read · ~1 pages · Grade level 11.8 · Accepted 2024-06-13 08:28:27
Filing Documents
- ea0207804-6k_alterity.htm (6-K) — 14KB
- ea020780401ex99-1_alterity.htm (EX-99.1) — 8KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001213900-24-052251.txt ( ) — 29KB
From the Filing
OF FOREIGN PRIVATE ISSUER SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-163 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Alterity Therapeutics Limited (Name of Registrant) Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073 , 333-248980 and 333-228671 ) and our Registration Statements on Form F-3 (Files No. 333-274816 , 333-251647 , 333-231417 and 333-250076 ) ALTERITY THERAPEUTICS LIMITED (a development stage enterprise) The following exhibits are submitted: 99.1 Alterity to Present at Hidden Gems in Life Sciences Webinar 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alterity Therapeutics Limited By: /s/ Geoffrey P. Kempler Geoffrey P. Kempler Chairman Date: June 13, 2024 2